Hiroshi Yoshida

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 51

Top Topics

Endometrial Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of personalized medicine

International journal of surgical pathology

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Mayumi Kobayashi Kato, Erisa Fujii, Yuka Asami, Yukihide Momozawa, Kengo Hiranuma, Masaaki Komatsu, Ryuji Hamamoto, Takahiro Ebata, Koji Matsumoto, Mitsuya Ishikawa, Takashi Kohno, Tomoyasu Kato, Hiroshi Yoshida, Kouya Shiraishi
Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer. Cancer science (2024)
Chiharu Mizoguchi, Tadaaki Nishikawa, Hiroshi Yoshida, Masanori Yasuda, Tomoyasu Kato, Kosei Hasegawa, Kan Yonemori
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma. Journal of gynecologic oncology (2024)
Yuto Kaimi, Tomoaki Naka, Hiroshi Yoshida, Masaya Uno, Akiko Miyagi Maeshima
Histopathology of peritonitis due to infectious mononucleosis with background Chlamydia trachomatis infection: A case report and literature review. Pathology international (2024)
Mariko Sasaki, Daiki Kato, Karin Murakami, Hiroshi Yoshida, Shohei Takase, Tsuguteru Otsubo, Hideaki Ogiwara
Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers. Nature communications 15 (1) (2024)
Mariko Sasaki, Daiki Kato, Karin Murakami, Hiroshi Yoshida, Shohei Takase, Tsuguteru Otsubo, Hideaki Ogiwara
Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers. Nature communications 15 (1) (2024)
Mayumi Kobayashi Kato, Erisa Fujii, Yuka Asami, Yukihide Momozawa, Kengo Hiranuma, Masaaki Komatsu, Ryuji Hamamoto, Takahiro Ebata, Koji Matsumoto, Mitsuya Ishikawa, Takashi Kohno, Tomoyasu Kato, Hiroshi Yoshida, Kouya Shiraishi
Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer. Cancer science 115 (5) (2024)
Mariko Sasaki, Daiki Kato, Karin Murakami, Hiroshi Yoshida, Shohei Takase, Tsuguteru Otsubo, Hideaki Ogiwara
Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers. Nature communications 15 (1) (2024)
Risako Ozawa, Tadaaki Nishikawa, Hiroshi Yoshida, Kouya Shiraishi, Tatsunori Shimoi, Tomoyasu Kato, Kan Yonemori
Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers. Journal of gynecologic oncology (2024)
Mayumi Kobayashi Kato, Erisa Fujii, Yuka Asami, Yukihide Momozawa, Kengo Hiranuma, Masaaki Komatsu, Ryuji Hamamoto, Takahiro Ebata, Koji Matsumoto, Mitsuya Ishikawa, Takashi Kohno, Tomoyasu Kato, Hiroshi Yoshida, Kouya Shiraishi
Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer. Cancer science 115 (5) (2024)
Mayumi Kobayashi Kato, Erisa Fujii, Yuka Asami, Yukihide Momozawa, Kengo Hiranuma, Masaaki Komatsu, Ryuji Hamamoto, Takahiro Ebata, Koji Matsumoto, Mitsuya Ishikawa, Takashi Kohno, Tomoyasu Kato, Hiroshi Yoshida, Kouya Shiraishi
Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer. Cancer science 115 (5) (2024)
Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto, Yoshito Komatsu, Makoto Ueno, Satoshi Kobayashi, Masafumi Ikeda, Mitsuhito Sasaki, Junji Furuse, Naohiro Okano, Nobuyoshi Hiraoka, Hiroshi Yoshida, Aya Kuchiba, Ryo Sadachi, Kenichi Nakamura, Naoko Matsui, Yoshiaki Nakamura, Wataru Okamoto, Takayuki Yoshino, Takuji Okusaka
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mariko Sasaki, Daiki Kato, Karin Murakami, Hiroshi Yoshida, Shohei Takase, Tsuguteru Otsubo, Hideaki Ogiwara
Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers. Nature communications 15 (1) (2024)
Mayumi Kobayashi Kato, Erisa Fujii, Yuka Asami, Yukihide Momozawa, Kengo Hiranuma, Masaaki Komatsu, Ryuji Hamamoto, Takahiro Ebata, Koji Matsumoto, Mitsuya Ishikawa, Takashi Kohno, Tomoyasu Kato, Hiroshi Yoshida, Kouya Shiraishi
Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer. Cancer science 115 (5) (2024)
Shigehiro Yagishita, Tadaaki Nishikawa, Hiroshi Yoshida, Daisuke Shintani, Sho Sato, Maiko Miwa, Mikiko Suzuki, Masanori Yasuda, Yusuke Ogitani, Takahiro Jikoh, Kan Yonemori, Kosei Hasegawa, Akinobu Hamada
Co-clinical study of [fam-] trastuzumab deruxtecan (DS8201a) in patient-derived xenograft models of uterine carcinosarcoma and its association with clinical efficacy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Tadaaki Nishikawa, Kosei Hasegawa, Koji Matsumoto, Masahiko Mori, Yasuyuki Hirashima, Kazuhiro Takehara, Kazuya Ariyoshi, Tomoyasu Kato, Shigehiro Yagishita, Akinobu Hamada, Mamiko Kawasaki, Satoshi Kawashima, Sawako Tomatsuri, Yukari Nagasaka, Hiroshi Yoshida, Ryunosuke Machida, Akihiro Hirakawa, Kenichi Nakamura, Kan Yonemori
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hiroshi Yoshida, Masaya Uno, Keisuke Ogimoto, Mayumi Kobayashi-Kato, Yasuhito Tanase, Mitsuya Ishikawa, Tomoyasu Kato
Endometrioid Endometrial Carcinoma With NKX3.1 Expression in a Transgender Man: A Case Report. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists (2023)
Hidenori Machino, Ai Dozen, Mariko Konaka, Masaaki Komatsu, Kohei Nakamura, Noriko Ikawa, Kanto Shozu, Ken Asada, Syuzo Kaneko, Hiroshi Yoshida, Tomoyasu Kato, Kentaro Nakayama, Vassiliki Saloura, Satoru Kyo, Ryuji Hamamoto
Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas. Experimental & molecular medicine (2023)
Ayumi Sugitani, Ayako Ogawa, Hiroshi Yoshida, Mayumi Kobayashi-Kato, Nao Kikkawa, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato
Ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets. International journal of surgical pathology (2023)
Hiroshi Yoshida, Kengo Hiranuma, Mariko Nakahara, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Kouya Shiraishi, Mitsuya Ishikawa, Tomoyasu Kato
Ovarian Mucinous Tumor Presenting Atypical Lobular Endocervical Glandular Hyperplasia-Like Appearance in a Patient With Germline STK11 p.F354L Variant: A Case Report. International journal of surgical pathology (2023)
Hitomi Sumiyoshi Okuma, Hiroshi Yoshida, Yoshihisa Kobayashi, Motoko Arakaki, Chiharu Mizoguchi, Lina Inagaki, Voon Pei Jye, Adam Malik Bin Ismail, Hwoei Fen Soo Hoo, Suhana Yusak, Marcelo Severino B Imasa, Thinh Nguyen Huy, Tu Thai Anh, Shinji Kohsaka, Hiroyuki Mano, Kan Yonemori, Kenichi Nakamura, Yasushi Yatabe
Molecular pathology quality control in Southeast Asia: Results of a Multiregional Quality Assurance Study from MASTER KEY Asia. Cancer science (2023)
Rui Kitadai, Tadaaki Nishikawa, Hiroshi Yoshida, Chiharu Mizoguchi, Kasumi Yamamoto, Tomoyasu Kato, Kan Yonemori
Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression. Journal of gynecologic oncology (2023)
Hiroshi Yoshida, Waku Takigawa, Mayumi Kobayashi Kato, Tadaaki Nishikawa, Kouya Shiraishi, Mitsuya Ishikawa
Mismatch Repair Protein Expression in Endometrial Cancer: Assessing Concordance and Unveiling Pitfalls in Two Different Immunohistochemistry Assays. Journal of personalized medicine 13 (8) (2023)
Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Takuya Ono, Ryuto Tsuchiya, Hiroshi Yoshida, Tohru Kiyono, Yutaka Yonemura, Tadashi Kondo
Correction: Noguchi et al. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei. J. Pers. Med. 2022, 12 , 258. Journal of personalized medicine 13 (9) (2023)
Kengo Hiranuma, Yuka Asami, Mayumi Kobayashi Kato, Naoya Murakami, Yoko Shimada, Maiko Matsuda, Shu Yazaki, Erisa Fujii, Kazuki Sudo, Ikumi Kuno, Masaaki Komatsu, Ryuji Hamamoto, Hideki Makinoshima, Koji Matsumoto, Mitsuya Ishikawa, Takashi Kohno, Yasuhisa Terao, Atsuo Itakura, Hiroshi Yoshida, Kouya Shiraishi, Tomoyasu Kato
Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis. Cancer medicine (2023)
Tadaaki Nishikawa, Kosei Hasegawa, Koji Matsumoto, Masahiko Mori, Yasuyuki Hirashima, Kazuhiro Takehara, Kazuya Ariyoshi, Tomoyasu Kato, Shigehiro Yagishita, Akinobu Hamada, Mamiko Kawasaki, Satoshi Kawashima, Sawako Tomatsuri, Yukari Nagasaka, Hiroshi Yoshida, Ryunosuke Machida, Akihiro Hirakawa, Kenichi Nakamura, Kan Yonemori
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Takuya Ono, Ryuto Tsuchiya, Hiroshi Yoshida, Tohru Kiyono, Yutaka Yonemura, Tadashi Kondo
Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei. Journal of personalized medicine 12 (2) (2022)
Ai Dozen, Kanto Shozu, Norio Shinkai, Noriko Ikawa, Rina Aoyama, Hidenori Machino, Ken Asada, Hiroshi Yoshida, Tomoyasu Kato, Ryuji Hamamoto, Syuzo Kaneko, Masaaki Komatsu
Tumor Suppressive Role of the PRELP Gene in Ovarian Clear Cell Carcinoma. Journal of personalized medicine 12 (12) (2022)
Hiroshi Yoshida, Masaya Uno, Tomoyasu Kato
Bartholin's glands commonly express NKX3.1: reconsideration of "prostatic differentiation" in gynaecological pathology. Histopathology 80 (6) (2022)
Takashi Natsume, Hiroshi Yoshida, Tadaaki Nishikawa, Nao Kikkawa, Tomoaki Naka, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato
Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge. International journal of surgical pathology (2022)
Naoki Kojima, Hiroshi Yoshida, Masaya Uno, Kengo Hiranuma, Tomoaki Naka, Kouya Shiraishi, Tomoyasu Kato
Microcystic stromal tumor of the ovary: a recurrent case with somatic CTNNB1 missense mutation. Virchows Archiv : an international journal of pathology 481 (5) (2022)
Ai Dozen, Kanto Shozu, Norio Shinkai, Noriko Ikawa, Rina Aoyama, Hidenori Machino, Ken Asada, Hiroshi Yoshida, Tomoyasu Kato, Ryuji Hamamoto, Syuzo Kaneko, Masaaki Komatsu
Tumor Suppressive Role of the PRELP Gene in Ovarian Clear Cell Carcinoma. Journal of personalized medicine 12 (12) (2022)
Mayumi Kobayashi Kato, Yuka Asami, Daisuke Takayanagi, Maiko Matsuda, Yoko Shimada, Kengo Hiranuma, Ikumi Kuno, Masaaki Komatsu, Ryuji Hamamoto, Koji Matsumoto, Mitsuya Ishikawa, Takashi Kohno, Tomoyasu Kato, Kouya Shiraishi, Hiroshi Yoshida
Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma. Cancer science 113 (5) (2022)
Ai Dozen, Kanto Shozu, Norio Shinkai, Noriko Ikawa, Rina Aoyama, Hidenori Machino, Ken Asada, Hiroshi Yoshida, Tomoyasu Kato, Ryuji Hamamoto, Syuzo Kaneko, Masaaki Komatsu
Tumor Suppressive Role of the PRELP Gene in Ovarian Clear Cell Carcinoma. Journal of personalized medicine 12 (12) (2022)
Sho-Ichi Kitamura, Hiroshi Yoshida, Mayumi Kobayashi-Kato, Nao Kikkawa, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato
Adenoid Basal Carcinoma with Adenoid Cystic Carcinoma Component of the Uterine Cervix: A Case Report and Literature Review. International journal of surgical pathology (2022)
Kosuke Yoshida, Akira Yokoi, Tomofumi Yamamoto, Yusuke Hayashi, Jun Nakayama, Tsuyoshi Yokoi, Hiroshi Yoshida, Tomoyasu Kato, Hiroaki Kajiyama, Yusuke Yamamoto
Aberrant Activation of Cell-Cycle-Related Kinases and the Potential Therapeutic Impact of PLK1 or CHEK1 Inhibition in Uterine Leiomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Ai Dozen, Kanto Shozu, Norio Shinkai, Noriko Ikawa, Rina Aoyama, Hidenori Machino, Ken Asada, Hiroshi Yoshida, Tomoyasu Kato, Ryuji Hamamoto, Syuzo Kaneko, Masaaki Komatsu
Tumor Suppressive Role of the PRELP Gene in Ovarian Clear Cell Carcinoma. Journal of personalized medicine 12 (12) (2022)
Shu Yazaki, Yuki Kojima, Hiroshi Yoshida, Shigemasa Takamizawa, Rui Kitadai, Tadaaki Nishikawa, Tatsunori Shimoi, Kazuki Sudo, Ayumi Saito, Hitomi Sumiyoshi Okuma, Maki Tanioka, Emi Noguchi, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Yasuhiro Fujiwara, Yuichiro Ohe, Kan Yonemori
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer. Journal of gynecologic oncology 33 (6) (2022)
Hiroshi Yoshida, Kouya Shiraishi, Tomoyasu Kato
Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers. Cancers 13 (24) (2021)
Hiroshi Yoshida, Tomoaki Naka, Mayumi Kobayashi-Kato, Nao Kikkawa, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato
Gastric-type cervical adenocarcinoma with squamous differentiation: buried in adenosquamous carcinomas? Virchows Archiv : an international journal of pathology 479 (2) (2021)
Hiroshi Yoshida, Tadaaki Nishikawa, Koji Matsumoto, Masahiko Mori, Yasuyuki Hirashima, Kazuhiro Takehara, Kazuya Ariyoshi, Kosei Hasegawa, Kan Yonemori
Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy. Virchows Archiv : an international journal of pathology 478 (6) (2021)
Hiroshi Yoshida, Yuka Asami, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Kouya Shiraishi, Tomoyasu Kato
Genetic features of endometrioid-type endometrial carcinoma arising in uterine adenomyosis. Virchows Archiv : an international journal of pathology (2021)
Hiroshi Yoshida, Hiroki Tanaka, Takafumi Tsukada, Naoko Abeto, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato
Diagnostic Discordance in Intraoperative Frozen Section Diagnosis of Ovarian Tumors: A Literature Review and Analysis of 871 Cases Treated at a Japanese Cancer Center. International journal of surgical pathology 29 (1) (2020)
Takeshi Ushigusa, Hiroshi Yoshida, Ikumi Kuno, Naoki Kojima, Mitsuya Ishikawa, Tomoyasu Kato
Characteristics and prognostic significance of incidentally detected cancer cells in uterine specimens of patients with pelvic high-grade serous carcinoma. Cytopathology : official journal of the British Society for Clinical Cytology 31 (2) (2020)
Naoki Kojima, Ikumi Kuno, Takeshi Ushigusa, Tomoyasu Kato, Hiroshi Yoshida
Chemotherapy-associated foam cell aggregates as a prognostic factor in patients with pelvic high-grade serous carcinoma receiving neo-adjuvant chemotherapy. Virchows Archiv : an international journal of pathology 477 (3) (2020)
Naoki Kojima, Hiroshi Yoshida, Takashi Uehara, Takeshi Ushigusa, Yuka Asami, Kouya Shiraishi, Tomoyasu Kato
Primary Clear Cell Adenocarcinoma of the Vulva: A Case Study With Mutation Analysis and Literature Review. International journal of surgical pathology 27 (7) (2019)
Naoki Kojima, Hiroshi Yoshida, Ikumi Kuno, Takashi Uehara, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato
Prognostic impact of intraoperative peritoneal cytology in interval debulking surgery for pelvic high-grade serous carcinoma. Cancer medicine 8 (10) (2019)
Keisei Tate, Hiroshi Yoshida, Mitsuya Ishikawa, Takashi Uehara, Shun Ichi Ikeda, Nobuyoshi Hiraoka, Tomoyasu Kato
Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy. Journal of gynecologic oncology 29 (3) (2018)
Yutaka Yoneoka, Hiroshi Yoshida, Mitsuya Ishikawa, Hanako Shimizu, Takashi Uehara, Takashi Murakami, Tomoyasu Kato
Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma. Journal of gynecologic oncology 30 (1) (2018)
Hourin Cho, Taiki Hashimoto, Hiroshi Yoshida, Hirokazu Taniguchi, Reiko Ogawa, Taisuke Mori, Nobuyoshi Hiraoka, Yutaka Saito, Shigeki Sekine
Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp. Histopathology 73 (4) (2018)
Keisei Tate, Reiko Watanabe, Hiroshi Yoshida, Hanako Shimizu, Takashi Uehara, Mitsuya Ishikawa, Shun-Ichi Ikeda, Nobuyoshi Hiraoka, Tomoyasu Kato
Uterine adenosarcoma in Japan: Clinicopathologic features, diagnosis and management. Asia-Pacific journal of clinical oncology 14 (4) (2018)
Hiroshi Yoshida, Kazuaki Shimada, Nobuyoshi Hiraoka
Infrequent mismatch repair protein loss in gallbladder cancer patients in Japan. Virchows Archiv : an international journal of pathology 470 (1) (2016)